SOPV, Solar Park Initiatives, Inc., SOPV.OB
SOPV is a solar energy company dedicated to utility and commercial solar park developments in North America.
SOPV intends to develop land for large utility scale solar photovoltaic (”PV”) projects.
SOPV will provide engineering, procurement of products and construction (”EPC”) via third party suppliers including its sister company Solar Energy Initiatives, Inc. SOPV will attempt to sell the resultant electrical production to various utilities and large commercial entities through a Power Purchase Agreement (”PPA”).
SOPV expects to provide energy savings to commercial and municipality users without any out of pocket engineering, procurement or construction (”EPC”) costs to those users of energy.
** SOPV has signed a Letter of Intent to develop a 1GW solar park in California **
SOPV has signed a Letter of Intent to develop approximately 5,000 acres of land for the design, construction and operation of up to a 1GW solar park in California. It is anticipated that the project will generate up to $3.5 Billion in revenue if fully completed.
SOPV will partner with a California developer to complete the project which is subject to permitting and financing approvals.
More about SOPV at www.solarparkinitiatives.com
PDC Energy (Nasdaq:PETD) plans to host a conference call with investors to discuss third quarter 2010 results on Monday, November 8, 2010, 1:00 p.m. EST
Descartes Systems Group (Nasdaq:DSGX) reported that its United-by-Design partner New Trend International Logistics Technology Ltd. (NYSE:NTI) deployed a Descartes Mobile Resource Management (MRM) 2.0 solution at Jiangsu Tobacco.
Jiangsu Tobacco selected Route Planner RS, part of the Descartes MRM 2.0 solution, to plan efficient delivery of its products to customers. DSGX's Route Planner RS solution is now deployed and fully operational across 13 major cities of Jiangsu Provence in China.
IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, reported that it has appointed Amin I. Khalifa as Corporate Vice President of Finance effective immediately, and as IRIS' Chief Financial Officer to be effective on the day immediately following the filing by the Company of its Form 10-Q for the third quarter of 2010.
Mr. Khalifa has approximately 30 years of senior finance and corporate management experience, having served as CFO of such companies as Apria Healthcare, Beckman Coulter, and Leap Wireless. Reporting directly to Cesar M. Garcia, Chairman, President and Chief Executive Officer of IRIS, Mr. Khalifa will oversee the Company's finance, accounting, investor relations and information technology functions.
He replaces Martin S. McDermut who served as Acting Chief Financial Officer since May 2010.
Alimera Sciences, Inc., (Nasdaq:ALIM), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, reported that data from its Phase 3 (FAME(tm)) clinical trials for Iluvien(r) will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
Iluvien is ALIM's investigational intravitreal insert being studied for diabetic macular edema (DME).
The presentation, by Baruch Kuppermann, M.D., Ph.D, professor and chief of the Retina Service at University of California, Irvine, is slated for 4:19 p.m., Saturday, October 16, during the Retina 2010 subspecialty day program.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.